Programmed death ligand 1 (PD-L1) is a typical immune checkpoint protein, whose up-
regulation on the membrane of different tumor cells inhibits the immune response of T cells …

Nanoparticle (NP)‐based vehicles are attractive for biomedical delivery and therapy, owing
to improved therapeutic efficiency and reduced adverse effects compared to free drugs …

Bioactive surfaces modified with functional peptides are critical for both fundamental
research and practical application of implant materials and tissue repair. However, when …

Molecular recognition in cell biological process is characterized with specific locks‐and‐
keys interactions between ligands and receptors, which are ubiquitously distributed on cell …

Cancer is one of the leading causes of death worldwide and poses a great threat to human
health. In the past few years, diverse molecular devices have been constructed by using …

Natural cells (NCs) can automatically and continuously respond to fluctuant external
information and distinguish meaningful stimuli from weak noise depending on their powerful …

Liquid biopsy allows noninvasive and real-time analysis of tumor-derived circulating targets
in body fluids, holding great value for cancer diagnosis, prognosis, personalized therapy, as …

Existing nucleic acid and antigen profiling methods for COVID-19 diagnosis fail to
simultaneously meet the demands in sensitivity and detection speed, hampering them from …

High levels of extracellular H+ and K+ are unique features of the tumor microenvironment
and have shown great promise for use in cancer-targeted drug delivery. Here, we design H+ …

DNA nanotechnology is a unique field that provides simple yet robust design techniques for
self-assembling nanoarchitectures with extremely high potential for biomedical applications …